Ratings by Raymond James (Tiago Fauth)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/8/2026 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 8/17/2026 | Rapport Therapeutics | RAPP | Maintain | Strong Buy (N/A) |
|
Details | ||
| 8/17/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Strong Buy (N/A) |
|
Details | ||
| 8/13/2026 | Polaryx Therapeutics | PLYX | New Coverage | Strong Buy (N/A) |
2.23 (2.02) |
-9.42% | Details | |
| 8/10/2026 | Tonix Pharma | TNXP | Maintain | Strong Buy (N/A) |
|
Details | ||
| 7/27/2026 | MapLight Therapeutics | MPLT | Maintain | Strong Buy (N/A) |
|
Details | ||
| 6/24/2026 | Tonix Pharma | TNXP | New Coverage | Strong Buy (N/A) |
11.96 (13.16) |
10.03% | Details | |
| 6/24/2026 | MapLight Therapeutics | MPLT | New Coverage | Strong Buy (N/A) |
28.64 (13.95) |
-51.29% | Details | |
| 5/7/2026 | Rapport Therapeutics | RAPP | Maintain | Strong Buy (N/A) |
|
Details | ||
| 4/9/2026 | PTC Therapeutics | PTCT | New Coverage | Outperform (N/A) |
71.26 (68.81) |
-3.44% | Details | |
| 4/9/2026 | Praxis Precision Medicines Inc. | PRAX | New Coverage | Strong Buy (N/A) |
320.22 (352.48) |
10.07% | Details | |
| 4/9/2026 | Jazz Pharmaceuticals | JAZZ | New Coverage | Outperform (N/A) |
195.93 (240.07) |
22.53% | Details | |
| 4/9/2026 | Ionis Pharmaceuticals | IONS | New Coverage | Outperform (N/A) |
74.98 (56.71) |
-24.37% | Details | |
| 4/9/2026 | Insmed | INSM | New Coverage | Outperform (N/A) |
160.18 (124.89) |
-22.03% | Details | |
| 4/9/2026 | Rapport Therapeutics | RAPP | New Coverage | Strong Buy (N/A) |
33.69 (46.09) |
36.81% | Details | |
| 4/9/2026 | United Therapeutics Corp. | UTHR | New Coverage | Outperform (N/A) |
581.69 (497.97) |
-14.39% | Details |
